Literature DB >> 10559281

Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation.

T Shimoike1, S Mimori, H Tani, Y Matsuura, T Miyamura.   

Abstract

To clarify the binding properties of hepatitis C virus (HCV) core protein and its viral RNA for the encapsidation, morphogenesis, and replication of HCV, the specific interaction of HCV core protein with its genomic RNA synthesized in vitro was examined in an in vivo system. The positive-sense RNA from the 5' end to nucleotide (nt) 2327, which covers the 5' untranslated region (5'UTR) and a part of the coding region of HCV structural proteins, interacted with HCV core protein, while no interaction was observed in the same region of negative-sense RNA and in other regions of viral and antiviral sense RNAs. The internal ribosome entry site (IRES) exists around the 5'UTR of HCV; therefore, the interaction of the core protein with this region of HCV RNA suggests that there is some effect on its cap-independent translation. Cells expressing HCV core protein were transfected with reporter RNAs consisting of nt 1 to 709 of HCV RNA (the 5'UTR of HCV and about two-thirds of the core protein coding regions) followed by a firefly luciferase gene (HCV07Luc RNA). The translation of HCV07Luc RNA was suppressed in cells expressing the core protein, whereas no significant suppression was observed in the case of a reporter RNA possessing the IRES of encephalomyocarditis virus followed by a firefly luciferase. This suppression by the core protein occurred in a dose-dependent manner. The expression of the E1 envelope protein of HCV or beta-galactosidase did not suppress the translation of both HCV and EMCV reporter RNAs. We then examined the regions that are important for suppression of translation by the core protein and found that the region from nt 1 to 344 was enough to exert this suppression. These results suggest that the HCV core protein interacts with viral genomic RNA at a specific region to form nucleocapsids and regulates the expression of HCV by interacting with the 5'UTR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559281      PMCID: PMC113018     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Deletion analysis of the capsid protein of Sindbis virus: identification of the RNA binding region.

Authors:  U Geigenmüller-Gnirke; H Nitschko; S Schlesinger
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

3.  Interaction between hepatitis C virus core protein and E1 envelope protein.

Authors:  S Y Lo; M J Selby; J H Ou
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Evidence for specificity in the encapsidation of Sindbis virus RNAs.

Authors:  B Weiss; H Nitschko; I Ghattas; R Wright; S Schlesinger
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation.

Authors:  N Ali; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Biosynthesis and biochemical properties of the hepatitis C virus core protein.

Authors:  E Santolini; G Migliaccio; N La Monica
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Internal processing of hepatitis C virus NS3 protein.

Authors:  I Shoji; T Suzuki; M Sato; H Aizaki; T Chiba; Y Matsuura; T Miyamura
Journal:  Virology       Date:  1999-02-15       Impact factor: 3.616

9.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Internal ribosome entry site within hepatitis C virus RNA.

Authors:  K Tsukiyama-Kohara; N Iizuka; M Kohara; A Nomoto
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  57 in total

1.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

2.  The 5' untranslated region and Gag product of Idefix, a long terminal repeat-retrotransposon from Drosophila melanogaster, act together to initiate a switch between translated and untranslated states of the genomic mRNA.

Authors:  Carine Meignin; Jean-Luc Bailly; Frédérick Arnaud; Bernard Dastugue; Chantal Vaury
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Membrane binding properties and terminal residues of the mature hepatitis C virus capsid protein in insect cells.

Authors:  Tomoaki Ogino; Hiroyuki Fukuda; Shinobu Imajoh-Ohmi; Michinori Kohara; Akio Nomoto
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus.

Authors:  Daniel M Jones; Ali M Atoom; Xiaozhen Zhang; Shyamasundaran Kottilil; Rodney S Russell
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

5.  Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.

Authors:  Kousuke Nakai; Toru Okamoto; Tomomi Kimura-Someya; Koji Ishii; Chang Kweng Lim; Hideki Tani; Eiko Matsuo; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tatsuo Miyamura; Jack H Nunberg; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

Review 6.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

7.  Molecular determinants for subcellular localization of hepatitis C virus core protein.

Authors:  Ryosuke Suzuki; Shinichiro Sakamoto; Takeya Tsutsumi; Akiko Rikimaru; Keiko Tanaka; Takashi Shimoike; Kohji Moriishi; Takuya Iwasaki; Kiyohisa Mizumoto; Yoshiharu Matsuura; Tatsuo Miyamura; Tetsuro Suzuki
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Brome mosaic virus capsid protein regulates accumulation of viral replication proteins by binding to the replicase assembly RNA element.

Authors:  Guanghui Yi; Ester Letteney; Chul-Hyun Kim; C Cheng Kao
Journal:  RNA       Date:  2009-02-23       Impact factor: 4.942

9.  Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.

Authors:  Kohji Moriishi; Tamaki Okabayashi; Kousuke Nakai; Kyoji Moriya; Kazuhiko Koike; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Ryosuke Suzuki; Tetsuro Suzuki; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.